Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.

@article{Sorensen2003LongtermEO,
  title={Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.},
  author={Ole Helmer Sorensen and Gordon M. Crawford and Henk Mulder and David Hosking and Carlo Gennari and Dan Mellstrom and Simon Pack and Dietrich Wenderoth and Cyrus Cooper and J-Y. Reginster},
  journal={Bone},
  year={2003},
  volume={32 2},
  pages={120-6}
}
Limited placebo-controlled data are available to assess the long-term fracture efficacy of bisphosphonates. In order to determine the effects of 5 years of risedronate treatment, we extended a 3-year, placebo-controlled vertebral fracture study in osteoporotic women for an additional 2 years; women who entered the extension study continued to receive 5 mg risedronate or placebo according to the original randomization, with maintenance of blinding. End points included vertebral and nonvertebral… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 74 extracted citations

Essentials of Menopause Management

Springer International Publishing • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…